MDGL Madrigal Pharmaceuticals, Inc.

379.10USD-4.45%Mkt Cap: 8.81B USDP/E: —

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directe…